177 related articles for article (PubMed ID: 21642594)
1. Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154.
Khanna N; Stuehler C; Conrad B; Lurati S; Krappmann S; Einsele H; Berges C; Topp MS
Blood; 2011 Jul; 118(4):1121-31. PubMed ID: 21642594
[TBL] [Abstract][Full Text] [Related]
2. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
Lugthart G; Albon SJ; Ricciardelli I; Kester MG; Meij P; Lankester AC; Amrolia PJ
J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
[TBL] [Abstract][Full Text] [Related]
4. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ma CK; Blyth E; Clancy L; Simms R; Burgess J; Brown R; Deo S; Micklethwaite KP; Gottlieb DJ
Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
[TBL] [Abstract][Full Text] [Related]
5. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
[TBL] [Abstract][Full Text] [Related]
6. Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer.
Bacher P; Jochheim-Richter A; Mockel-Tenbrink N; Kniemeyer O; Wingenfeld E; Alex R; Ortigao A; Karpova D; Lehrnbecher T; Ullmann AJ; Hamprecht A; Cornely O; Brakhage AA; Assenmacher M; Bonig H; Scheffold A
Cytotherapy; 2015 Oct; 17(10):1396-405. PubMed ID: 26188965
[TBL] [Abstract][Full Text] [Related]
7. Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections.
Stuehler C; Nowakowska J; Bernardini C; Topp MS; Battegay M; Passweg J; Khanna N
J Infect Dis; 2015 Apr; 211(8):1251-61. PubMed ID: 25367298
[TBL] [Abstract][Full Text] [Related]
8. Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus.
Jiang W; Withers B; Sutrave G; Clancy LE; Yong MI; Blyth E
Curr Hematol Malig Rep; 2019 Aug; 14(4):247-260. PubMed ID: 31228095
[TBL] [Abstract][Full Text] [Related]
9. Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers.
Leibold J; Feucht J; Halder A; Stevanovic S; Kayser S; Handgretinger R; Feuchtinger T
J Immunother; 2012; 35(9):661-9. PubMed ID: 23090075
[TBL] [Abstract][Full Text] [Related]
10. CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.
Sukdolak C; Tischer S; Dieks D; Figueiredo C; Goudeva L; Heuft HG; Verboom M; Immenschuh S; Heim A; Borchers S; Mischak-Weissinger E; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1480-92. PubMed ID: 23891747
[TBL] [Abstract][Full Text] [Related]
11. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific T cells for the treatment of infections after transplantation.
Einsele H
Hematol J; 2003; 4(1):10-7. PubMed ID: 12692515
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
Ramadan G
Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
[TBL] [Abstract][Full Text] [Related]
15. Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells.
Tischer S; Priesner C; Heuft HG; Goudeva L; Mende W; Barthold M; Kloeß S; Arseniev L; Aleksandrova K; Maecker-Kolhoff B; Blasczyk R; Koehl U; Eiz-Vesper B
J Transl Med; 2014 Dec; 12():336. PubMed ID: 25510656
[TBL] [Abstract][Full Text] [Related]
16. Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.
Gerdemann U; Keirnan JM; Katari UL; Yanagisawa R; Christin AS; Huye LE; Perna SK; Ennamuri S; Gottschalk S; Brenner MK; Heslop HE; Rooney CM; Leen AM
Mol Ther; 2012 Aug; 20(8):1622-32. PubMed ID: 22801446
[TBL] [Abstract][Full Text] [Related]
17. CD123 redirected multiple virus-specific T cells for acute myeloid leukemia.
Zhou L; Liu X; Wang X; Sun Z; Song XT
Leuk Res; 2016 Feb; 41():76-84. PubMed ID: 26740053
[TBL] [Abstract][Full Text] [Related]
18. Capture and generation of adenovirus specific T cells for adoptive immunotherapy.
Chatziandreou I; Gilmour KC; McNicol AM; Costabile M; Sinclair J; Cubitt D; Campbell JD; Kinnon C; Qasim W; Gaspar HB
Br J Haematol; 2007 Jan; 136(1):117-26. PubMed ID: 17092305
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant.
Regn S; Raffegerst S; Chen X; Schendel D; Kolb HJ; Roskrow M
Bone Marrow Transplant; 2001 Jan; 27(1):53-64. PubMed ID: 11244438
[TBL] [Abstract][Full Text] [Related]
20. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
Feuchtinger T; Lang P; Hamprecht K; Schumm M; Greil J; Jahn G; Niethammer D; Einsele H
Exp Hematol; 2004 Mar; 32(3):282-9. PubMed ID: 15003314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]